Microbial reductions of aromatic carboxylic acids, usually to their corresponding alcohols, have been observed with wholecell biotransformations by a number of microorganisms, including Actinomyces (17), Clostridium thermoaceticum (31), Aspergillus niger (2, 24), Corynespora melonis (2), Coriolus (2), Neurospora (3), Glomerella cingulata (29, 30), Gloeosporium laeticolor (30), and Nocardia (8, 18). In all reported cases, substrates contained an aromatic moiety, although not all directly attached to the carboxyl groups being reduced to the corresponding alcohols. When the carbon next to the carboxyl group was chiral, the reduction displayed different degrees of enantioselectivity (8,29,30). The enantioselective step of this reduction has never been studied. Gross and Zenk found that in Neurospora crassa, an aldehyde intermediate was formed as a carboxylic acid was reduced to an alcohol (13,14). The enzyme reducing aryl carboxylic acids to aldehydes was purified and identified as a monomeric protein with an apparent molecular mass of 120,000 Da (13). The reduction required ATP, Mg 2ϩ , and NADPH as cofactors (13). Further work showed that this enzyme catalyzed the initial reaction between an aromatic acid and ATP to form an acyl-AMP intermediate which was subsequently reduced by NADPH to form the aldehyde (Fig. 1) (12). This enzyme was named as an aryl aldehyde oxidoreductase (EC 1.2.1.30).Kato et al. showed that Nocardia asteroides JCM 3016 could transform benzoic acid to benzyl alcohol (18). The enzyme from this organism reduces benzoic acid to benzaldehyde with ATP, NADPH, and Mg 2ϩ as cofactors. The K m values for benzoic acid, NADPH, and ATP were 260, 6, and 23 nM, respectively. A number of mono-and multisubstituted benzoic acids can be reduced by the enzyme. This aryl aldehyde oxidoreductase can also catalyze the reduction of benzoyl-AMP by NADPH (19). The Nocardia enzyme was purified, and it was proposed that it reduced benzoate by the same mechanism as the Neurospora enzyme (12).In our laboratory, a strain of Nocardia (NRRL 5646) was found to efficiently reduce aryl carboxylic acids to give aldehydes and alcohols. With this organism, the substrate specificity for carboxylic acids appears to be significantly different than that for the enzyme reported by Kato et al. (19). Whole-cell reductions with Nocardia sp. strain NRRL 5646 were highly enantioselective with ibuprofen isomers as substrates (8). We now report a rapid purification method, the characterization of the enzyme, the enantioselectivity of the enzyme with two isomers of ibuprofen, and the range of reductions of a series of aryl carboxylic acid substrates.
MATERIALS AND METHODS
Materials.A Mono-Q anion exchanger, hydroxyapatite, and molecular weight standards for gel electrophoresis were purchased from Bio-Rad (Hercules, Calif.). Polyvinylidene difluoride membranes were from Applied Biosystems (Foster City, Calif.). (S)-(ϩ)-␣-Methyl-4-(2-methylpropyl)-benzeneacetic acid (ibuprofen) was from Aldrich (Milwaukee, Wis.). The (R)-(Ϫ) isomer of ibuprofe...